{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:05:25Z","timestamp":1784189125927,"version":"3.55.0"},"reference-count":42,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Cardiac involvement in sarcoidosis necessitates meticulous management, with accurate and timely diagnosis being crucial. The hybrid positron emission tomography\/magnetic resonance imaging (PET\/MRI) modality is an emerging diagnostic tool for cardiac sarcoidosis, offering potential advantages over the use of independent PET and MRI techniques for both diagnosis and prognosis. Methods: Following the PRISMA guidelines for study selection, a comprehensive search using the terms \u201chybrid PET\/MRI\u201d and\/or \u201ccardiac sarcoidosis\u201d identified a total of 10 eligible studies. Results: Patients were primarily middle-aged males. Overall, hybrid PET\/MR enhanced diagnostic accuracy by identifying specific subgroups, detecting active disease, enabling detailed quantitative analysis, and assessing regional involvement. Additionally, it offered valuable insights that could improve phenotyping and prognostic predictions. The primary limitation was the longer duration of a single scan; however, the total scanning time was reduced compared to conducting two separate procedures. Conclusions: Hybrid PET\/MR imaging offers several significant advantages over separate imaging modalities when diagnosing cardiac sarcoidosis, including increased diagnostic accuracy and comprehensive tissue characterization. Further comparative studies are needed to fully understand its clinical impact and potential limitations.<\/jats:p>","DOI":"10.3390\/jcm15145563","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:34:23Z","timestamp":1784172863000},"page":"5563","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Hybrid PET-MRI in the Diagnosis and Management of Cardiac Sarcoidosis\u2014A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Salmane","family":"Nasri Elmi","sequence":"first","affiliation":[{"name":"GKT School of Medicine, King\u2019s College London, London WC2R 2LS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3802-0181","authenticated-orcid":false,"given":"Marina","family":"Sennaraj","sequence":"additional","affiliation":[{"name":"GKT School of Medicine, King\u2019s College London, London WC2R 2LS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharan J.","family":"Kapadia","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4168-0589","authenticated-orcid":false,"given":"Ali","family":"Malik","sequence":"additional","affiliation":[{"name":"GKT School of Medicine, King\u2019s College London, London WC2R 2LS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukruth","family":"Kundur","sequence":"additional","affiliation":[{"name":"GKT School of Medicine, King\u2019s College London, London WC2R 2LS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9586-0163","authenticated-orcid":false,"given":"\u0141ukasz","family":"Ma\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Nursing, Faculty of Rehabilitation, University of Physical Education, 00-968 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3227-3295","authenticated-orcid":false,"given":"Sanjay","family":"Sivalokanathan","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.semdp.2018.09.001","article-title":"Reprint of: The pathology of pulmonary sarcoidosis: Update","volume":"35","author":"Ma","year":"2018","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ebiom.2016.04.024","article-title":"Diagnostic Performance of Bronchoalveolar Lavage Fluid CD4\/CD8 Ratio for Sarcoidosis: A Meta-analysis","volume":"8","author":"Shen","year":"2016","journal-title":"eBioMedicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"eaar8356","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4(+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: Recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: Evolving concepts in diagnosis and treatment","volume":"35","author":"Lynch","year":"2014","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Shah, H.H., Zehra, S.A., Shahrukh, A., Waseem, R., Hussain, T., Hussain, M.S., Batool, F., and Jaffer, M. (2023). Cardiac sarcoidosis: A comprehensive review of risk factors, pathogenesis, diagnosis, clinical manifestations, and treatment strategies. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1156474"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14797\/mdcvj.1057","article-title":"Epidemiology, Pathogenesis, and Diagnosis of Cardiac Sarcoidosis","volume":"18","author":"Mathai","year":"2022","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e027971","DOI":"10.1161\/JAHA.122.027971","article-title":"Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis","volume":"12","author":"Ueberham","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_10","first-page":"63","article-title":"Complications of endomyocardial biopsy in heart transplant patients","volume":"12","author":"Levin","year":"1993","journal-title":"J. Heart Lung Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.semnuclmed.2024.02.004","article-title":"Imaging of Cardiac Sarcoidosis: An Update and Future Aspects","volume":"54","author":"Saric","year":"2024","journal-title":"Semin. Nucl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement from the American Heart Association","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"106609","DOI":"10.1016\/j.jaccas.2025.106609","article-title":"Sarcoidosis Masquerading as Hypertrophic Cardiomyopathy","volume":"31","author":"Sivalokanathan","year":"2026","journal-title":"JACC Case Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_16","unstructured":"The EndNote Team (2013). EndNote, Clarivate."},{"key":"ref_17","unstructured":"Microsoft Corporation (2025). Microsoft Excel, Microsoft Corporation."},{"key":"ref_18","first-page":"2127","article-title":"Methodological quality of case series studies: An introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2023.11.010","article-title":"Hybrid Magnetic Resonance Positron Emission Tomography Is Associated with Cardiac-Related Outcomes in Cardiac Sarcoidosis","volume":"17","author":"Trivieri","year":"2024","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1007\/s12350-018-01578-8","article-title":"Same day comparison of PET\/CT and PET\/MR in patients with cardiac sarcoidosis","volume":"27","author":"Wisenberg","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/RLU.0000000000001669","article-title":"Initial Experience with Simultaneous 18F-FDG PET\/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis","volume":"42","author":"Hanneman","year":"2017","journal-title":"Clin. Nucl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jcmg.2021.08.018","article-title":"Hybrid Cardiac Magnetic Resonance\/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active from Chronic Cardiac Sarcoidosis","volume":"15","author":"Greulich","year":"2022","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","journal-title":"Eur. J. Hybrid. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography\/Computed Tomography in the Assessment of Cardiac Sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e220292","DOI":"10.1148\/ryct.220292","article-title":"Combined FDG PET\/MRI versus Standard-of-Care Imaging in the Evaluation of Cardiac Sarcoidosis","volume":"5","author":"Marschner","year":"2023","journal-title":"Radiol. Cardiothorac. Imaging"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid Magnetic Resonance Imaging and Positron Emission Tomography with Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12350-020-02359-y","article-title":"Diagnostic utility of fusion (18)F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis","volume":"29","author":"Okune","year":"2022","journal-title":"J. Nucl. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Angeli, F., Armillotta, M., Fo\u00e0, A., Fedele, D., Russo, V., Bonfiglioli, R., Baldovini, C., Mosconi, C., Paolisso, P., and Amicone, S. (J. Am. Coll. Cardiol. Imging, 2026). Diagnostic Accuracy of an Integrated Multimodality Imaging Approach in Patients with Cardiac Masses, J. Am. Coll. Cardiol. Imging, in press.","DOI":"10.1016\/j.jcmg.2026.03.014"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients with Suspected Cardiac Sarcoidosis Is Associated with Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1007\/s00330-020-06765-1","article-title":"Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis","volume":"30","author":"Symons","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","article-title":"Ventricular tachycardia in cardiac sarcoidosis: Characterization of ventricular substrate and outcomes of catheter ablation","volume":"8","author":"Kumar","year":"2015","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_33","first-page":"50","article-title":"Cardiac sarcoidosis-state of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_34","first-page":"e210","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"138","author":"Stevenson","year":"2018","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","article-title":"A Joint Procedural Position Statement on Imaging in Cardiac Sarcoidosis: From the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology","volume":"25","author":"Glaudemans","year":"2018","journal-title":"J. Nucl. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bartoli, L., Angeli, F., Stefanizzi, A., Fabrizio, M., Paolisso, P., Bergamaschi, L., Broccoli, A., Zinzani, P.L., Gali\u00e8, N., and Rucci, P. (2022). Genetics and clinical phenotype of Erdheim-Chester disease: A case report of constrictive pericarditis and a systematic review of the literature. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.876294"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12410-015-9320-6","article-title":"Myocardial Inflammation\u2014Are We There Yet?","volume":"8","author":"Greulich","year":"2015","journal-title":"Curr. Cardiovasc. Imaging Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation","volume":"72","author":"Ferreira","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1007\/s12350-019-01788-8","article-title":"Preparation is everything: The impact of a structured preparation protocol on cardiac (18)F-FDG PET imaging for cardiac sarcoidosis","volume":"28","author":"Divakaran","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12968-021-00827-z","article-title":"Society for Cardiovascular Magnetic Resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations","volume":"24","author":"Hundley","year":"2022","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Munoz, C., Schneider, A., Botnar, R.M., and Prieto, C. (2022). Recent advances in PET-MRI for cardiac sarcoidosis. Front. Nucl. Med., 2.","DOI":"10.3389\/fnume.2022.1032444"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jcmg.2021.12.012","article-title":"Another Step Toward Integrated MR\/PET as Favored Imaging Modality in Cardiac Sarcoidosis","volume":"15","author":"Schindler","year":"2022","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5563\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:24:58Z","timestamp":1784186698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":42,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15145563"],"URL":"https:\/\/doi.org\/10.3390\/jcm15145563","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}